Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00078130
NCT00078130CompletedPhase 3

Bup/Nx - Facilitated Rehab for Opioid Dependent Adolescents

University of Pennsylvania4 sites in 1 country223 target enrollmentStarted: July 1, 2003Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Drugs

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
223
Locations
4
Primary Endpoint
Opiate abstinence
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual, a 7-14 day detoxification with buprenorphine and three weeks of psychosocial therapy.

Study Design

Study Type
Interventional
Primary Purpose
Treatment

Eligibility Criteria

Ages
14 Years to 21 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Male and non-pregnant female subjects seeking outpatient treatment for opioid dependence with physiological features without serious medical or psychiatric disorders.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Opiate abstinence

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other

Study Sites (4)

Loading locations...

Similar Trials

Completed
Phase 4
Extended Release Naltrexone for Opioid-Dependent YouthDrug Dependence
NCT01843023Friends Research Institute, Inc.288
Enrolling By Invitation
Phase 4
Randomized Trial of Narcotic vs Non-Narcotic Pain Modulation After Labrum RepairPostoperative Pain, AcuteOpioid UseLabral Tear, Glenoid
NCT05974423The Cooper Health System60
Withdrawn
Not Applicable
Treatment of Temporomandibular Disorders in Children and AdolsecentsMyalgiaArthralgia of TMJTemporomandibular Disorder
NCT03849534Karolinska Institutet150
Completed
Phase 2
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2Opioid-Related DisordersSubstance-Related Disorders
NCT00000319Yale University
Withdrawn
Phase 2
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2Opioid-Related DisordersHeroin Dependence
NCT00000327University of Colorado, Denver